Bench-to-bedside translation of magnetic nanoparticles

被引:61
|
作者
Singh, Dhirender [1 ,2 ]
McMillan, JoEllyn M. [2 ]
Kabanov, Alexander V. [3 ]
Sokolsky-Papkov, Marina [3 ]
Gendelman, Howard E. [1 ,2 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[3] Univ N Carolina, UNC Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC USA
关键词
biocompatibility; drug targeting; magnetic hyperthermia; MRI; nanoparticle; targeted drug and gene delivery; tissue engineering; IRON-OXIDE NANOPARTICLES; BLOOD-BRAIN-BARRIER; DRUG-DELIVERY; GENE DELIVERY; IN-VIVO; TARGETED DELIVERY; REENGINEERING BIOPHARMACEUTICALS; BIOMEDICAL APPLICATIONS; PLGA NANOPARTICLES; OXIDATIVE STRESS;
D O I
10.2217/nnm.14.5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Magnetic nanoparticles (MNPs) are a new and promising addition to the spectrum of biomedicines. Their promise revolves around the broad versatility and biocompatibility of the MNPs and their unique physicochemical properties. Guided by applied external magnetic fields, MNPs represent a cutting-edge tool designed to improve diagnosis and therapy of a broad range of inflammatory, infectious, genetic and degenerative diseases. Magnetic hyperthermia, targeted drug and gene delivery, cell tracking, protein bioseparation and tissue engineering are but a few applications being developed for MNPs. MNPs toxicities linked to shape, size and surface chemistry are real and must be addressed before clinical use is realized. This article presents both the promise and perils of this new nanotechnology, with an eye towards opportunity in translational medical science.
引用
收藏
页码:501 / 516
页数:16
相关论文
共 50 条
  • [1] Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
    Corbo, Vincenzo
    Tortora, Giampaolo
    Scarpa, Aldo
    CURRENT DRUG TARGETS, 2012, 13 (06) : 744 - 752
  • [2] Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis
    Mignani, Serge
    Rodrigues, Joao
    Tomas, Helena
    Roy, Rene
    Shi, Xiangyang
    Majoral, Jean-Pierre
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 136 : 73 - 81
  • [3] 3D kidney organoids for bench-to-bedside translation
    Gupta, Navin
    Dilmen, Emre
    Morizane, Ryuji
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (04): : 477 - 487
  • [4] 3D kidney organoids for bench-to-bedside translation
    Navin Gupta✉
    Emre Dilmen
    Ryuji Morizane
    Journal of Molecular Medicine, 2021, 99 : 477 - 487
  • [5] A venetoclax bench-to-bedside story
    Courtney D. DiNardo
    Marina Y. Konopleva
    Nature Cancer, 2021, 2 : 3 - 5
  • [6] Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challenges
    Tan, Chalet
    Waldmann, Thomas A.
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (07) : 895 - 898
  • [7] A venetoclax bench-to-bedside story
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    NATURE CANCER, 2021, 2 (01) : 3 - 5
  • [8] Bench-to-bedside pharmacology of adrenomedullin
    Kato, Johji
    Kitamura, Kazuo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 : 140 - 148
  • [9] Getting from bench-to-bedside
    Nielsen, Vivien
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [10] Bench-to-bedside review: Lactate and the kidney
    Bellomo R.
    Critical Care, 6 (4): : 322 - 326